Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Nature Structural Biology

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/79047PMID 10966654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Jak-STAT pathway.

  2000cited by this paper
• Erythropoietin receptor activation by a ligand-induced conformation change.

  1999cited by this paper
• Ruminant Placental Lactogens Act as Antagonists to Homologous Growth Hormone Receptors and as Agonists to Human or Rabbit Growth Hormone Receptors*

  1999cited by this paper
• Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity.

  1999cited by this paper
• Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.

  1999cited by this paper
• The structure, organization, activation and plasticity of the erythropoietin receptor.

  1999cited by this paper
• Efficiency of signalling through cytokine receptors depends critically on receptor orientation

  1998cited by this paper
• Crystallization of ovine placental lactogen in a 1:2 complex with the extracellular domain of the rat prolactin receptor.

  1998cited by this paper
• Structural basis for cytokine hormone-receptor recognition and receptor activation.

  1998cited by this paper
• Cloning, preparation and characterization of biologically active recombinant caprine placental lactogen.

  1998cited by this paper
• An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation

  1998cited by this paper
• The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex.

  1998cited by this paper
• Large-scale preparation and characterization of recombinant ovine placental lactogen.

  1997cited by this paper
• Direct evidence that lactogenic hormones induce homodimerization of membrane‐anchored prolactin receptor in intact Nb2‐11C rat lymphoma cells

  1997cited by this paper
• Real-time Kinetic Measurements of the Interactions between Lactogenic Hormones and Prolactin-Receptor Extracellular Domains from Several Species Support the Model of Hormone-induced Transient Receptor Dimerization*

  1996cited by this paper
• Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals.

  1996cited by this paper
• Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å

  1996cited by this paper
• Preparation and characterization of recombinant prolactin receptor extracellular domain from rat.

  1995cited by this paper
• Extracellular domain of prolactin receptor from bovine mammary gland: expression in Escherichia coli, purification and characterization of its interaction with lactogenic hormones.

  1995cited by this paper
• Structural variants of prolactin: occurrence and physiological significance.

  1995cited by this paper
• A hot spot of binding energy in a hormone-receptor interface

  1995cited by this paper
• Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

  1995cited by this paper
• Biological activity and immunological reactivity of human prolactin mutants.

  1995cited by this paper
• The X-ray structure of a growth hormone–prolactin receptor complex

  1994cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors

  1994cited by this paper
• Signaling by the cytokine receptor superfamily: JAKs and STATs.

  1994cited by this paper
• Enhancement of the method of molecular replacement by incorporation of known structural information.

  1994cited by this paper
• Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2.

  1994cited by this paper
• Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.

  1993cited by this paper
• The crystal structure of a mutant human lysozyme C77/95A with increased secretion efficiency in yeast.

  1992cited by this paper
• Rational design of potent antagonists to the human growth hormone receptor.

  1992cited by this paper
• Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.

  1992cited by this paper
• Preparation, purification, and determination of the biological activities of 12 N terminus-truncated recombinant analogues of bovine placental lactogen.

  1992cited by this paper
• Free R value: a novel statistical quantity for assessing the accuracy of crystal structures

  1992cited by this paper
• Identification of ligand binding determinants of the prolactin receptor.

  1992cited by this paper
• Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

  1992cited by this paper
• Rational design of receptor-specific variants of human growth hormone.

  1991cited by this paper
• The growth hormone/prolactin receptor gene family.

  1991cited by this paper
• Structural design and molecular evolution of a cytokine receptor superfamily.

  1990cited by this paper
• Zinc mediation of the binding of human growth hormone to the human prolactin receptor.

  1990cited by this paper
• A new cytokine receptor superfamily.

  1990cited by this paper
• Cloning and expression of ovine placental lactogen.

  1989cited by this paper
• Three-dimensional structure of a genetically engineered variant of porcine growth hormone.

  1987cited by this paper
• Structural features of prolactins and growth hormones that can be related to their biological properties.

  1986cited by this paper
• Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors

  1986cited by this paper
• The interpretation of protein structures: estimation of static accessibility.

  1971cited by this paper

• A long-lasting prolactin stimulates galactopoiesis in mice

  2025cites this paper
• Prolactin drives cortical neuron maturation and dendritic development during murine embryonic stem cell differentiation

  2025cites this paper
• Cryo-EM structure of the extracellular domain of murine Thrombopoietin Receptor in complex with Thrombopoietin

  2024cites this paper
• Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery

  2024cites this paper
• A long-acting prolactin to combat lactation insufficiency

  2023cites this paper
• Structural modeling of cytokine-receptor-JAK2 signaling complexes using AlphaFold Multimer

  2023cites this paper
• A cautionary tale: Alien prolactins may induce lesser, no, or opposite effects to homologous hormone!

  2022cites this paper
• THE ROLE OF PROLACTIN RECEPTOR SIGNALING IN LIVER HOMEOSTASIS AND DISEASE

  2021cites this paper
• Molecular Breeding of Three Genes Associated with Egg Production Traits in Three Strains of Chickens. J. World Poult. Res., 10 (4): 605-614. DOI: https://dx.doi.org/10.36380/jwpr.2020.69;

  2021cites this paper
• 50 Years of structural immunology

  2021cites this paper
• Molecular Breeding of Three Genes Associated with Egg Production Traits in Three Strains of Chickens

  2020cites this paper
• Dynamic Regulation of JAK-STAT Signaling Through the Prolactin Receptor Predicted by Computational Modeling

  2020cites this paper
• The molecular details of cytokine signaling via the JAK/STAT pathway

  2018cites this paper
• Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity.

  2017cites this paper
• The role of protein dynamics in the aggregation of biopharmaceuticals

  2016cites this paper
• A combined computational and structural model of the full-length human prolactin receptor

  2016cites this paper
• Leptin and the OB-receptor as anti-obesity target: recent in silico advances in the comprehension of the protein-protein interaction and rational drug design of anti- obesity lead compounds.

  2014cites this paper
• Stromal–epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer

  2012cites this paper
• Analysis of the genetic effects of prolactin gene polymorphisms on chicken egg production

  2012cites this paper
• Genetic effect of the prolactin receptor gene on egg production traits in chickens.

  2012cites this paper
• Molecular mechanisms of prolactin and its receptor.

  2012cites this paper
• Identification of the disulfide bonds of lysyl oxidase

  2011cites this paper
• Investigation of Prolactin Receptor Activation and Blockade Using Time-Resolved Fluorescence Resonance Energy Transfer

  2011cites this paper
• Functional epitopes for site 1 of human prolactin.

  2011cites this paper
• Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.

  2010cites this paper
• Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone.

  2010cites this paper
• Erythropoietin Receptor as a Paradigm for Cytokine Signaling

  2010cites this paper
• Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2*

  2010cites this paper
• Activating the Prolactin Receptor: Effect of the Ligand on the Conformation of the Extracellular Domain.

  2010cites this paper
• Intramolecular Disulfide Bonds of the Prolactin Receptor Short Form Are Required for Its Inhibitory Action on the Function of the Long Form of the Receptor (cid:1)

  2009cites this paper
• Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors

  2008cites this paper
• Native and recombinant bovine placental lactogens.

  2008cites this paper
• S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain.

  2008cites this paper
• Structure-based rationale for interleukin 5 receptor antagonism.

  2008cites this paper
• Rational Design of Competitive Prolactin/Growth Hormone Receptor Antagonists

  2008cites this paper
• Crystal Structure of a Prolactin Receptor Antagonist Bound to the Extracellular Domain of the Prolactin Receptor*

  2008cites this paper
• Cross-crystal averaging reveals that the structure of the peptidyl-transferase center is the same in the 70S ribosome and the 50S subunit

  2008cites this paper
• Intramolecular Disulfide Bonds of the Prolactin Receptor Short Form Are Required for Its Inhibitory Action on the Function of the Long Form of the Receptor

  2008cites this paper
• From Bench to Bedside: Future Potential for the Translation of Prolactin Inhibitors as Breast Cancer Therapeutics

  2008cites this paper
• Identifying Functional Epitopes In Site 1 Of Human Prolactin Hormone

  2008cites this paper
• Protein Recognition in Biology

  2008cites this paper
• Interaction of lysyl oxidase with the hormone placental lactogen and its effecton mammary epithelial cell proliferation and migration

  2008cites this paper
• High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.

  2007cites this paper
• Structural and Thermodynamic Bases for the Design of Pure Prolactin Receptor Antagonists

  2007cites this paper
• Award Number: W81XWH-06-1-0448 TITLE: The Role of Constitutively Active Prolactin Receptors in the Natural History of Breast Cancer

  2007cites this paper
• Seamless Integration of Detection and Therapy for Breast Cancer using Targeted Engineered Nanoparticles

  2007cites this paper
• Development of Prolactin Receptor Antagonists: Same Goal, Different Ways

  2007cites this paper
• Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization.

  2006cites this paper
• Discovery of eight novel divergent homologs expressed in cattle placenta.

  2006cites this paper
• Synchronous selection of homing peptides for multiple tissues by in vivo phage display

  2006cites this paper
• Crystal structure and site 1 binding energetics of human placental lactogen.

  2006cites this paper
• Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD) subcloned from chicken leptin receptor.

  2005cites this paper
• Development and potential clinical uses of human prolactin receptor antagonists.

  2005cites this paper
• The potential role of potent prolactin antagonists as chemotherapeutics for human cancers : an evaluation of select prolactin antagonists in human breast cancer cells.

  2005cites this paper
• Cytokine recognition by human interleukin 5 receptor.

  2005cites this paper
• Solution structure of human prolactin.

  2005cites this paper
• Discovery of protein-protein interactions of the lysyl oxidase enzyme : implications for cardiovascular disease, cancer and fibrosis

  2005cites this paper
• Quantitative FRET imaging of leptin receptor oligomerization kinetics in single cells

  2005cites this paper
• Association of polymorphisms for prolactin and prolactin receptor genes with broody traits in chickens.

  2005cites this paper
• A model of the ternary complex of interleukin-10 with its soluble receptors

  2005influential citation
• Prediction of orthologous relationship by functionally important sites

  2005cites this paper
• Receptor Epitope Usage by an Interleukin-5 Mimetic Peptide*

  2005cites this paper
• Kinetic Interaction Analysis of Human Interleukin 5 Receptor α Mutants Reveals a Unique Binding Topology and Charge Distribution for Cytokine Recognition*

  2004cites this paper
• Mapping of the Leptin Binding Sites and Design of a Leptin Antagonist*

  2004cites this paper
• The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors.

  2004cites this paper
• NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.

  2004cites this paper
• Mechanism for ordered receptor binding by human prolactin.

  2004cites this paper
• Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.

  2004cites this paper
• Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3.

  2003cites this paper
• CHAPTER 6 – Prolactin

  2003cites this paper
• CHAPTER 44 – Erythropoietin Receptor as a Paradigm for Cytokine Signaling

  2003cites this paper
• Molecular Basis for Binding Multiple Cytokines by γc

  2003cites this paper
• Growth Hormone and Prolactin Family of Hormones and Receptors: The Structural Basis for Receptor Activation and Regulation

  2003cites this paper
• The N-terminus of human prolactin modulates its biological properties.

  2003cites this paper
• Natriuretic Peptide Receptor A Activation Stabilizes a Membrane-distal Dimer Interface*

  2003cites this paper
• Molecular characterization of prostate hyperplasia in prolactin transgenic mice

  2003cites this paper
• Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization

  2003cites this paper
• Site2 binding energetics of the regulatory step of growth hormone–induced receptor homodimerization

  2003cites this paper
• The tertiary structure and backbone dynamics of human prolactin.

  2003cites this paper
• Prolactin: the new biology of an old hormone.

  2002cites this paper
• Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites.

  2002cites this paper
• Treatment of immune neuropathies

  2002cites this paper
• Subcloning, Expression, Purification, and Characterization of Recombinant Human Leptin-binding Domain*

  2002cites this paper
• Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function

  2002cites this paper
• Structure of the extracellular domains of the human interleukin-6 receptor α-chain

  2002cites this paper
• Sequence conservation in families whose members have little or no sequence similarity: the four-helical cytokines and cytochromes.

  2002cites this paper
• Growth Hormone and Prolactin—Molecular and Functional Evolution

  2002cites this paper
• Crystal structures of alpha-helical cytokine-receptor complexes: we've only scratched the surface.

  2002cites this paper
• Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.

  2002cites this paper
• Mechanism of ruminant placental lactogen action: molecular and in vivo studies.

  2002cites this paper
• The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome

  2002cites this paper
• Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain.

  2002cites this paper
• Relative localization of the prolactin receptor binding sites for lactogenic hormones.

  2001cites this paper
• The structure and activity of a monomeric interferon-gamma:alpha-chain receptor signaling complex.

  2001cites this paper
• Progress in Guillain-Barré syndrome.

  2001cites this paper
• The Structure and Activity of a Monomeric Interferon-γ:α-Chain Receptor Signaling Complex

  2001cites this paper
• Mutations of ovine and bovine placental lactogens change, in different ways, the biological activity mediated through homologous and heterologous lactogenic receptors.

  2001cites this paper
• Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)

  2001cites this paper